ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: SA-PO1062

Cancer in Hemodialysis Patients

Session Information

Category: Dialysis

  • 701 Dialysis: Hemodialysis and Frequent Dialysis

Author

  • Navarrete, Jose E., Emory University, Atlanta, Georgia, United States
Background

Describe the incidence of cancer in hemodialysis patients. Describe the most common types of cancer in hemodialysis patients.

Methods

Incident hemodialysis patients enrolled in the Emory Dialysis program form 1/2011 to 12/2015 were followed until the diagnosis of cancer, death or censoring up to 12/31/2018. Time from inititation of dialysis to diagnosis of cancer and type of cancer was recorded.

Results

902 patients were enrrolled in the hemodialysis program. 25 (2.8%) patients with prior cancer were excluded from the analysis as well as 51 patients followed less than a month. The remaining 826 patients are the base of this report. 51 patients (6.2%) developed a new cancer. Cancer patients were older (65 vs 57). The cumulative risk of cancer is presented in figure 1 (11%). The most common cancers were urological (20%), paraproteinemia (20%), prostate (17%), gastrointestinal (8%), lung (8%), breast (6%), gynecological (6%), liver (4%), skin (4%) and brain, adrenals and unknown primary with 1% (Figure 2)

Conclusion

The cumulative risk of cancer was 11% over 8 years. Cancer patients were older and had a lower hemoglobin. Urological, paraproteinemias and other solid organ cancers represent the majority of cancer diagnosed and this information could be used to delineate strategies for early detection of cancer in hemodialysis patients.